Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial
- 25 June 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 396 (10252), 669-683
- https://doi.org/10.1016/s0140-6736(20)31358-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to OutcomesJournal of Invasive Cardiology, 2017
- Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysisThe Lancet, 2016
- 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trialThe Lancet, 2015
- Comparison of Balloon-Expandable vs Self-expandable Valves in Patients Undergoing Transcatheter Aortic Valve ReplacementJAMA, 2014
- Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve ImplantationJournal of Invasive Cardiology, 2012
- Transcatheter Aortic Valve Replacement With the St. Jude Medical Portico ValveJournal of Invasive Cardiology, 2012
- Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk PatientsThe New England Journal of Medicine, 2011
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryThe New England Journal of Medicine, 2010
- Frailty in Older Adults: Evidence for a PhenotypeThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2001
- Progress in Development of the Index of ADLThe Gerontologist, 1970